Balanced news tone
News Sentiment
APTX sentiment intelligence
Apotex Health Corp. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
91/100 classification confidence.
directly relevant articles
high-authority source matches
+11.9% over one week, +31.1% over four weeks, trend inactive, and near fair-value range.
Coalition targets health insurance costs, calls for relief
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Coalition targets health insurance costs, calls for relief
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jul 2026 00:05
- Source
- The Times-Tribune, Scranton, Pa.
Desjardins says Apotex Health is a buy
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 14 Jul 2026 16:43
- Source
- Cantech Letter
Why Apotex Health (TSX:APTX) Is Up 7.1% After First Generic Semaglutide Approval In Canada
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 07 Jul 2026 08:51
- Source
- simplywall.st
Analysts bullish on Apotex as they initiate coverage following Canadian drugmaker's IPO
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 07 Jul 2026 07:00
- Source
- Financial Post
Apotex Health Corp. Price Target Announced at C$40.00/Share by Scotia
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 06 Jul 2026 15:27
- Source
- Moomoo
Gross profit of Apotex Health Corp. – TSX:APTX
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 24 Jun 2026 16:33
- Source
- TradingView
Apotex Health Corp. Cash Flow – TSX:APTX
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 22 Jun 2026 10:35
- Source
- TradingView
Apotex Health (TSX:APTX) Stock Could Be 51.7% Below Fair Value After Its IPO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jun 2026 07:00
- Source
- simplywall.st
Apotex Health Corp (APTX-T) Stock Price and News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 12:35
- Source
- The Globe and Mail
Apotex CEO says IPO provides greater growth potential despite more scrutiny
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- BNN Bloomberg
APOTEX HEALTH CORP. ANNOUNCES CLOSING OF UPSIZED INITIAL PUBLIC OFFERING AND EXERCISE OF OVER-ALLOTMENT OPTION IN FULL
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- PR Newswire Canada
Apotex Health (TSX:APTX) Stock Valuation Check As P/E Premium Conflicts With DCF Discount
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Market source
Apotex Health Corp. (APTX) Opens the Market
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- TMX Newsfile
Apotex Health IPO Highlights TMX Group’s Growing Role In Life Sciences
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- simplywall.st
Apotex Health Corp (APTX:CT): Stock Price, Quote and News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 15:31
- Source
- BNN Bloomberg
SK Capital-backed Apotex raises C$1.3bn for IPO
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- pehub.com
Apotex Health prices upsized IPO at $24 per share
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- Investment Executive
Apotex Health prices upsized initial public offering at $24 per share
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- BNN Bloomberg
Toronto Stock Exchange Welcomes Apotex
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- The Globe and Mail
Apotex Shares Rally as Trading Begins Following Pricing of C$1.3 Billion IPO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- WSJ
Apotex Health shares jump in largest Toronto stock market IPO since 2021
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- Reuters
Apotex Health shares jump 17% in Toronto market debut
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- Investing.com
APOTEX HEALTH CORP. FILES FINAL PROSPECTUS AND ANNOUNCES PRICING OF UPSIZED INITIAL PUBLIC OFFERING
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- TradingView
Canadian health firm Apotex prices IPO at top end, raising C$1.3 billion
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- Market source
APOTEX HEALTH CORP. UPSIZES ITS INITIAL PUBLIC OFFERING
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jun 2026 07:00
- Source
- TradingView
Apotex Health seeks to raise up to C$1.2 billion, potentially reviving Toronto IPO market
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Reuters
Apotex looking to sell about $1 billion in shares in initial public offering
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Yahoo! Finance Canada
Canadian Drugmaker Apotex Files For Toronto IPO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- Bloomberg.com
Apotex Health files preliminary prospectus for initial public offering of shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- Yahoo! Finance Canada
Apotex expected to fetch $10-billion valuation as drugmaker files to go public on TSX
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- The Globe and Mail